Grip strength (average of two trials) was measured using an isometric dynamometer (Jamar Hydraulic Hand Dynamometer, Lafayette, IN) in a seated position to the nearest 2 kg.
Again by way of explanation, quality of life outcomes for the sciatica trial were measured using the SF36 instrument, translated to the SF-6D and its associated utilities.
Disease activity throughout the trial was measured using disease activity indices and monitoring blood.
In clinical trials, ADHD symptoms were measured using the ADHD Rating Scale, Version IV, and several parent-, teander-, and patient-rated scales.
Using the dominant hand, two trials of handgrip strength were measured using the dynamometer (Smedley's Dynamo Meter, Tokyo) and the mean recorded.
In both trials, wind speed and direction were measured using a Delta-T Type AN1 anemometer and a Delta-T Type Wd1 potentiometer, which had been placed in the middle of the field and just a few centimetres above the spikes.
Treatment integrity in completing critical steps of discrete-trial and backward chaining procedures were measured using a multiple baseline design across participants, counterbalanced for procedures.
In a blinded retrospective analysis of 588 ER-positive tamoxifen-treated and untreated breast cancer patients from the randomised prospective Stockholm trial, H : I and MGI were measured using real-time RT PCR.
In all trials, pain intensity and pain relief were measured using a standard four-point categorical pain intensity scale (0 none, 1 mild, 2 moderate, 3 severe) and a five-point point pain relief scale (0 none, 1 a little, 2 some, 3 a lot, 4 complete).
In all trials, PCT was measured using a rapid, sensitive assay with a functional assay sensitivity of 0.06 μg/L (KRYPTOR PCT; B∙R∙A∙H∙M∙S, Hennigsdorf, Germany) and an assay time of less than 20 minutes.
